EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed EphrinB2

Molecular Cancer Research

Volumn 8, Issue 10, 2010, Pages 1297-1309

  Héroult, Mélanie ^a,b,f   Schaffner, Florence ^c,g   Pfaff, Dennis ^a,b,h   Prahst, Claudia ^a,b,i   Kirmse, Robert ^b,j   Kutschera, Simone ^a,b   Riedel, Maria ^a   Ludwig, Thomas ^b,k   Vajkoczy, Peter ^e   Graeser, Ralph ^d   Augustin, Hellmut G ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c TUMOR BIOLOGY CENTER   (Germany)

^d PROQINASE GMBH   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f BAYER PHARMA AG   (Germany)

^g SCRIPPS RESEARCH INSTITUTE   (United States)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ INSERM   (France)

^j UNIVERSITY OF COLORADO   (United States)

^k DANONE RESEARCH   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN B2; EPHRIN RECEPTOR B4; LUCIFERASE;

ARTICLE; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MELANOMA CELL; METASTASIS; MICROVASCULATURE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL ADHESION; CELL COMMUNICATION; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; EPHRIN-B2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTOR, EPHB4;

EID: 78649651321     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0453     Document Type: Article

References (53)

1. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.
2. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-8.
3. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-5.
4. Hart IR, Fidler IJ. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 1980;40:2281-7.
5. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-6. (Pubitemid 32225831)
6. Johnson RC, Zhu D, Augustin-Voss HG, Pauli BU. Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung-metastatic rat breast and prostate carcinoma cells. J Cell Biol 1993;121:1423-32.
7. Pauli BU, Augustin-Voss HG, el-Sabban ME, Johnson RC, Hammer DA. Organ-preference of metastasis. The role of endothelial cell adhesion molecules. Cancer Metastasis Rev 1990;9:175-89.
8. Rossi MC, Zetter BR. Selective stimulation of prostatic carcinoma cell proliferation by transferrin. Proc Natl Acad Sci U S A 1992;89:6197-201.
9. Menter DG, Herrmann JL, Nicolson GL. The role of trophic factors and autocrine/paracrine growth factors in brain metastasis. Clin Exp Metastasis 1995;13:67-88.
10. Minn AJ, Kang Y, Serganova I, et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 2005;115:44-55.
11. Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005;436:518-24.
12. Landemaine T, Jackson A, Bellahcene A, et al. A six-gene signature predicting breast cancer lung metastasis. Cancer Res 2008;68:6092-9.
13. Klein R. Eph/ephrin signaling in morphogenesis, neural development and plasticity. Curr Opin Cell Biol 2004;16:580-9.
14. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007;8:464-78.
15. Poliakov A, Cotrina M, Wilkinson DG. Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell 2004;7:465-80.
16. Noren NK, Foos G, Hauser CA, Pasquale EB. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol 2006;8:815-25.
17. Kumar SR, Singh J, Xia G, et al. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol 2006;169:279-93.
18. Xia G, Kumar SR, Masood R, et al. EphB4 expression and biological significance in prostate cancer. Cancer Res 2005;65:4623-32.
19. Takai N, Miyazaki T, Fujisawa K, Nasu K, Miyakawa I. Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer. Oncol Rep 2001;8:567-73. (Pubitemid 33758456)
20. Xia G, Kumar SR, Stein JP, et al. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene 2006;25:769-80.
21. Masood R, Kumar SR, Sinha UK, et al. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck. Int J Cancer 2006;119:1236-48.
22. Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc Natl Acad Sci U S A 2004;101:5583-8.
23. Kertesz N, Krasnoperov V, Reddy R, et al. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-2 interaction, modulates angiogenesis, and inhibits tumor growth. Blood 2006;107:2330-8.
24. Batlle E, Bacani J, Begthel H, et al. EphB receptor activity suppresses colorectal cancer progression. Nature 2005;435:1126-30.
25. Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 2010;10:165-80.
26. Adams RH, Diella F, Hennig S, Helmbacher F, Deutsch U, Klein R. The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration. Cell 2001;104:57-69.
27. Fuller T, Korff T, Kilian A, Dandekar G, Augustin HG. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells. J Cell Sci 2003;116:2461-70.
28. Korff T, Dandekar G, Pfaff D, et al. Endothelial ephrinB2 is controlled by microenvironmental determinants and associates context-dependently with CD31. Arterioscler Thromb Vasc Biol 2006;26:468-74.
29. Pfaff D, Heroult M, Riedel M, et al. Involvement of endothelial ephrinB2 in adhesion and transmigration of EphB expressing monocytes. J Cell Sci 2008;121:3842-50.
30. Korff T, Braun J, Pfaff D, Augustin HG, Hecker M. Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment. Blood 2008;112:73-81.
31. Pfaff D, Fiedler U, Augustin HG. Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking. J Leukoc Biol 2006;80:719-26.
32. Martiny-Baron G, Korff T, Schaffner F, et al. Inhibition of tumor growth and angiogenesis by soluble EphB4. Neoplasia 2004;6:248-57.
33. Ludwig T, Kirmse R, Poole K, Schwarz US. Probing cellular microenvironments and tissue remodeling by atomic force microscopy. Pflugers Arch 2008;456:29-49.
34. Franz CM, Taubenberger A, Puech PH, Muller DJ. Studying integrin-mediated cell adhesion at the single-molecule level using AFM force spectroscopy. Sci STKE 2007:pl5.
35. Fidler IJ. Host and tumour factors in cancer metastasis. Eur J Clin Invest 1990;20:481-6.
36. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006;127:679-95.
37. Nguyen DX, Bos PD, Massagué J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2006;9:274-84.
38. Mimeault M, Batra SK. New promising drug targets in cancer- and metastasis-initiating cells. Drug Discov Today 2010;15:354-64.
39. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007;7:834-46.
40. Kumar SR, Scehnet JS, Ley EJ, et al. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res 2009;69:3736-45.
41. Steeg PS. Cancer: micromanagement of metastasis. Nature 2007;449:671-3.
42. Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS. Breast cancer metastasis to the central nervous system. Am J Pathol 2005;167:913-20.
43. Mannori G, Santoro D, Carter L, Corless C, Nelson RM, Bevilacqua MP. Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin. Am J Pathol 1997;151:233-43.
44. Kim YJ, Borsig L, Varki NM, Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A 1998;95:9325-30.
45. Jain S, Zuka M, Liu J, et al. Platelet glycoprotein Ibα supports experimental lung metastasis. Proc Natl Acad Sci U S A 2007;104:9024-8.
46. Palumbo JS, Talmage KE, Massari JV, et al. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood 2007;110:133-41.
47. Zhu DZ, Cheng CF, Pauli BU. Mediation of lung metastasis of murine melanomas by a lung-specific endothelial cell adhesion molecule. Proc Natl Acad Sci U S A 1991;88:9568-72.
48. Brown DM, Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004;5:365-74.
49. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14.
50. Miao H, Strebhardt K, Pasquale EB, Shen TL, Guan JL, Wang B. Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases. J Biol Chem 2005;280:923-32.
51. George SE, Simokat K, Hardin J, Chisholm AD. The VAB-1 Eph receptor tyrosine kinase functions in neural and epithelial morphogenesis in C. elegans. Cell 1998;92:633-43.
52. Yang NY, Pasquale EB, Owen LB, Ethell IM. The EphB4 receptor tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization. J Biol Chem 2006;281:32574-86.
53. Sakamoto H, Zhang XQ, Suenobu S, Ohbo K, Ogawa M, Suda T. Cell adhesion to ephrinb2 is induced by EphB4 independently of its kinase activity. Biochem Biophys Res Commun 2004;321:681-7.